Literature DB >> 26919435

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

Dominik Sturm1,2, Brent A Orr3, Umut H Toprak4, Volker Hovestadt5, David T W Jones1, David Capper6,7, Martin Sill8, Ivo Buchhalter4, Paul A Northcott1, Irina Leis6, Marina Ryzhova9, Christian Koelsche6,7, Elke Pfaff1,2, Sariah J Allen3, Gnanaprakash Balasubramanian10, Barbara C Worst1,2, Kristian W Pajtler1, Sebastian Brabetz1, Pascal D Johann1,2, Felix Sahm6,7, Jüri Reimand11,12, Alan Mackay13, Diana M Carvalho13, Marc Remke14, Joanna J Phillips15,16,17, Arie Perry15,16,17, Cynthia Cowdrey15, Rachid Drissi18, Maryam Fouladi18, Felice Giangaspero19,20, Maria Łastowska21, Wiesława Grajkowska21, Wolfram Scheurlen22, Torsten Pietsch23, Christian Hagel24, Johannes Gojo25,26, Daniela Lötsch26, Walter Berger26, Irene Slavc25, Christine Haberler27, Anne Jouvet28, Stefan Holm29, Silvia Hofer30, Marco Prinz31, Catherine Keohane32, Iris Fried33, Christian Mawrin34, David Scheie35, Bret C Mobley36, Matthew J Schniederjan37, Mariarita Santi38, Anna M Buccoliero39, Sonika Dahiya40, Christof M Kramm41, André O von Bueren41, Katja von Hoff42, Stefan Rutkowski42, Christel Herold-Mende43, Michael C Frühwald44, Till Milde2,45, Martin Hasselblatt46, Pieter Wesseling47,48, Jochen Rößler49, Ulrich Schüller50, Martin Ebinger51, Jens Schittenhelm52, Stephan Frank53, Rainer Grobholz54, Istvan Vajtai55, Volkmar Hans56, Reinhard Schneppenheim42, Karel Zitterbart57, V Peter Collins58, Eleonora Aronica59, Pascale Varlet60, Stephanie Puget61, Christelle Dufour62, Jacques Grill62, Dominique Figarella-Branger63, Marietta Wolter64, Martin U Schuhmann65, Tarek Shalaby66, Michael Grotzer66, Timothy van Meter67, Camelia-Maria Monoranu68, Jörg Felsberg64, Guido Reifenberger64, Matija Snuderl69, Lynn Ann Forrester70, Jan Koster71, Rogier Versteeg71, Richard Volckmann71, Peter van Sluis71, Stephan Wolf72, Tom Mikkelsen73, Amar Gajjar74, Kenneth Aldape75, Andrew S Moore76, Michael D Taylor14, Chris Jones13, Nada Jabado77, Matthias A Karajannis78, Roland Eils4,79,80, Matthias Schlesner4, Peter Lichter5,80, Andreas von Deimling6,7, Stefan M Pfister1,2, David W Ellison3, Andrey Korshunov6,7, Marcel Kool1.   

Abstract

Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly aggressive, poorly differentiated embryonal tumors occurring predominantly in young children but also affecting adolescents and adults. Herein, we demonstrate that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors. From the remaining fraction of CNS-PNETs, we identify four new CNS tumor entities, each associated with a recurrent genetic alteration and distinct histopathological and clinical features. These new molecular entities, designated "CNS neuroblastoma with FOXR2 activation (CNS NB-FOXR2)," "CNS Ewing sarcoma family tumor with CIC alteration (CNS EFT-CIC)," "CNS high-grade neuroepithelial tumor with MN1 alteration (CNS HGNET-MN1)," and "CNS high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)," will enable meaningful clinical trials and the development of therapeutic strategies for patients affected by poorly differentiated CNS tumors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26919435      PMCID: PMC5139621          DOI: 10.1016/j.cell.2016.01.015

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  40 in total

1.  The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.

Authors:  A Buijs; L van Rompaey; A C Molijn; J N Davis; A C Vertegaal; M D Potter; C Adams; S van Baal; E C Zwarthoff; M F Roussel; G C Grosveld
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  BEN: a novel domain in chromatin factors and DNA viral proteins.

Authors:  Saraswathi Abhiman; Lakshminarayan M Iyer; L Aravind
Journal:  Bioinformatics       Date:  2008-01-18       Impact factor: 6.937

3.  Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes.

Authors:  C G Eberhart; D J Brat; K J Cohen; P C Burger
Journal:  Pediatr Dev Pathol       Date:  2000 Jul-Aug

4.  Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes.

Authors:  Andrey Korshunov; Marc Remke; Marco Gessi; Marina Ryzhova; Thomas Hielscher; Hendrik Witt; Vivienne Tobias; Anna Maria Buccoliero; Iacopo Sardi; Marina Paola Gardiman; Jose Bonnin; Bernd Scheithauer; Andreas E Kulozik; Olaf Witt; Sverre Mork; Andreas von Deimling; Otmar D Wiestler; Felice Giangaspero; Marc Rosenblum; Torsten Pietsch; Peter Lichter; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2010-04-21       Impact factor: 17.088

5.  Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.

Authors:  Reinhard Schneppenheim; Michael C Frühwald; Stefan Gesk; Martin Hasselblatt; Astrid Jeibmann; Uwe Kordes; Markus Kreuz; Ivo Leuschner; Jose Ignacio Martin Subero; Tobias Obser; Florian Oyen; Inga Vater; Reiner Siebert
Journal:  Am J Hum Genet       Date:  2010-02-04       Impact factor: 11.025

6.  Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

Authors:  David Capper; Susanne Weissert; Jörg Balss; Antje Habel; Jochen Meyer; Diana Jäger; Ulrike Ackermann; Claudia Tessmer; Andrey Korshunov; Hanswalter Zentgraf; Christian Hartmann; Andreas von Deimling
Journal:  Brain Pathol       Date:  2009-10-27       Impact factor: 6.508

7.  Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.

Authors:  Meihua Li; Kyle F Lee; Yuntao Lu; Ian Clarke; David Shih; Charles Eberhart; V Peter Collins; Tim Van Meter; Daniel Picard; Limei Zhou; Paul C Boutros; Piergiorgio Modena; Muh-Lii Liang; Steve W Scherer; Eric Bouffet; James T Rutka; Scott L Pomeroy; Ching C Lau; Michael D Taylor; Amar Gajjar; Peter B Dirks; Cynthia E Hawkins; Annie Huang
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

8.  The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription.

Authors:  K H M van Wely; M A Meester-Smoor; M J F W Janssen; A-J Aarnoudse; G C Grosveld; E C Zwarthoff
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

9.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more
  238 in total

1.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

2.  DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.

Authors:  Felix K F Kommoss; Damian Stichel; Daniel Schrimpf; Mark Kriegsmann; Basile Tessier-Cloutier; Aline Talhouk; Jessica N McAlpine; Kenneth T E Chang; Dominik Sturm; Stefan M Pfister; Laura Romero-Pérez; Thomas Kirchner; Thomas G P Grünewald; Rolf Buslei; Hans-Peter Sinn; Gunhild Mechtersheimer; Peter Schirmacher; Dietmar Schmidt; Hans-Anton Lehr; Felix Sahm; David G Huntsman; C Blake Gilks; Friedrich Kommoss; Andreas von Deimling; Christian Koelsche
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-25       Impact factor: 4.553

3.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

Review 4.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

5.  CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.

Authors:  Inga-Marie Schaefer; Paola Dal Cin; Latrice M Landry; Christopher D M Fletcher; Glenn J Hanna; Christopher A French
Journal:  Genes Chromosomes Cancer       Date:  2018-08-14       Impact factor: 5.006

6.  PregOMICS-Leveraging systems biology and bioinformatics for drug repurposing in maternal-child health.

Authors:  Jeffery A Goldstein; Lisa A Bastarache; Joshua C Denny; Jill M Pulley; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

7.  Subgroup-specific outcomes of children with malignant childhood brain tumors treated with an irradiation-sparing protocol.

Authors:  Eveline Teresa Hidalgo; Matija Snuderl; Cordelia Orillac; Svetlana Kvint; Jonathan Serrano; Peter Wu; Matthias A Karajannis; Sharon L Gardner
Journal:  Childs Nerv Syst       Date:  2019-08-02       Impact factor: 1.475

8.  Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.

Authors:  Kohei Fukuoka; Yasin Mamatjan; Ruth Tatevossian; Michal Zapotocky; Scott Ryall; Ana Guerreiro Stucklin; Julie Bennett; Liana Figueiredo Nobre; Anthony Arnoldo; Betty Luu; Ji Wen; Kaicen Zhu; Alberto Leon; Dax Torti; Trevor J Pugh; Lili-Naz Hazrati; Normand Laperriere; James Drake; James T Rutka; Peter Dirks; Abhaya V Kulkarni; Michael D Taylor; Ute Bartels; Annie Huang; Gelareh Zadeh; Kenneth Aldape; Vijay Ramaswamy; Eric Bouffet; Matija Snuderl; David Ellison; Cynthia Hawkins; Uri Tabori
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

Review 9.  Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.

Authors:  Sydney T Grob; Jean M Mulcahy Levy
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

10.  KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1.

Authors:  Sarah J Wong; Micah D Gearhart; Alexander B Taylor; David R Nanyes; Daniel J Ha; Angela K Robinson; Jason A Artigas; Oliver J Lee; Borries Demeler; P John Hart; Vivian J Bardwell; Chongwoo A Kim
Journal:  Structure       Date:  2016-08-25       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.